Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)-Reference-Cited by-同舟云学术

Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)

Published:2016-04 Issue:10026 Volume:387 Page:1415-1426
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Barlesi Fabrice,Mazieres Julien,Merlio Jean-Philippe,Debieuvre Didier,Mosser Jean,Lena Hervé,Ouafik L'Houcine,Besse Benjamin,Rouquette Isabelle,Westeel Virginie,Escande Fabienne,Monnet Isabelle,Lemoine Antoinette,Veillon Rémi,Blons Hélène,Audigier-Valette Clarisse,Bringuier Pierre-Paul,Lamy Régine,Beau-Faller Michèle,Pujol Jean-Louis,Sabourin Jean-Christophe,Penault-Llorca Frédérique,Denis Marc G,Lantuejoul Sylvie,Morin Franck,Tran Quân,Missy Pascale,Langlais Alexandra,Milleron Bernard,Cadranel Jacques,Soria Jean-Charles,Zalcman Gérard

Publisher

Elsevier BV

Subject

General Medicine

Reference30 articles.

1. Cancer statistics, 2013;Siegel;CA Cancer J Clin,2013

2. Hallmarks of cancer: the next generation;Hanahan;Cell,2011

3. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;Lynch;N Engl J Med,2004

4. Crizotinib versus chemotherapy in advanced ALK-positive lung cancer;Shaw;N Engl J Med,2013

5. Signatures of mutational processes in human cancer;Alexandrov;Nature,2013

Cited by 810 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-ALK autoantibodies in patients with ALK-positive Non-Small Cell Lung Cancer (NSCLC): A monocentric experience;The Journal of Liquid Biopsy;2024-12

2. Encorafenib plus binimetinib for BRAF V600E-mutant metastatic NSCLC: clinical implications of the phase 2 PHAROS study;Future Oncology;2024-09-03

3. RACGAP1 is a pivotal gene in lung adenocarcinoma-associated membranous nephropathy: Based on comprehensive bioinformatics analysis and machine learning;International Immunopharmacology;2024-09

4. Discovery of a Potential Inhibitor Against Lung Cancer: Computational Approaches and Molecular Dynamics Study;PHYS CHEM RES;2024

5. CD4 ⁺ tumor-infiltrating lymphocytes secreting T cell-engagers induce regression of autologous patient-derived non-small cell lung cancer xenografts;OncoImmunology;2024-08-27